期刊文献+

氨氯地平阿托伐他汀钙片治疗高血压合并冠状动脉粥样硬化性心脏病的疗效研究 被引量:1

下载PDF
导出
摘要 临床心血管疾病当中,血压合并冠状动脉粥样硬化性心脏病(冠心病)十分常见,可引起心悸、心绞痛与乏力等症状,危害性非常大[1]。近几年中,生活水平的提升,饮食结构的改变,使得越来越多的人罹患了高血压疾病,而高血压的发生会引起血压持续增高的情况,使得血流动力学发生改变,对血中血小板造成了刺激,引起了动脉粥样病变的情况,使得心肌缺氧/缺血甚至是坏死,进而导致了冠心病[2]。目前,高血压并冠心病患者,临床尚无特异性药物,临床心血管病防治指南中,对冠心病二级预防基础性药物多选择他汀类药物。单纯西药对高血压并冠心病患者未取得显著效果,而复方制剂药物的应用,对改善患者病情取得一定效果。此研究,笔者旨在分析高血压合并冠心病中氨氯地平阿托伐他汀钙片的应用价值,现报告如下。
作者 罗光辉
出处 《实用医技杂志》 2020年第12期1660-1662,共3页 Journal of Practical Medical Techniques
  • 相关文献

参考文献7

二级参考文献67

  • 1成威,周胜华,张铭,李旭平.阿托伐他汀对高血压肾病蛋白尿及C-反应蛋白和白介素-6的影响[J].高血压杂志,2005,13(12):767-770. 被引量:43
  • 2Vanuzzo D, Pilotto L, Mirolo R, et al. Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation[J]. G Ital Cardiol,2008,9(Suppl 1):S6-17.
  • 3Kannel WB. Risk stratification in hypertension: new insights from the Framingham study[J]. Am J Hypertens,2000,13(1Pt 2):S3-10.
  • 4Cherry SB, Benner JS, Hussein MA, et al. The clinical and economic burden of nonadherence with antihypertensive and lipidlowering therapy in hypertensive patients[J]. Value Health, 2009, 12(4):489-497.
  • 5Zhou MS, Tian R, Jaimes EA, et al. Combination therapy of am- lodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension[J]. Am J Hypertens, 2014,27(6):873-880.
  • 6Curran MP. Amlodipine/atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease[J]. Drugs,2010,70(2) :191-213.
  • 7Riley WA. Carotid intima-media thickness: risk assessment and scanning protocol[J]. Eur Heart J,2002,23(12):916-918.
  • 8Crouse JR, Harpold GH, Kahl FR, et al. Evaluation of a scoring system for extraeranial carotid atherosclerosis extent with B-mode ultrasound[J]. Stroke, 1986,17 (2) : 270-275.
  • 9Asia pacific cohort studies collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region[J]. Circulation, 2005,112 (22) : 3384-3390.
  • 10Sever PS, Dahlo{ B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA): a muhicentre randomized controlled trial [J]. Lancet,2003,361(9364) :1149-1158.

共引文献2440

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部